S&P 500 4,005.59 (+0.07%)

DOW 32,522.38 (-0.12%)

QQQ 311.03 (+0.22%)

AAPL 160.14 (+0.54%)

MSFT 276.13 (+0.86%)

META 202.54 (+0.19%)

GOOGL 105.11 (+0.18%)

AMZN 100.14 (-0.47%)

TSLA 197.17 (-0.21%)

NVDA 269.77 (+2.97%)

NIO 9.43 (+1.73%)

BABA 85.12 (+1.70%)

AMD 96.76 (+0.87%)

T 18.57 (+0.16%)

F 11.86 (+1.19%)

MU 58.69 (+0.10%)

CGC 1.97 (-0.25%)

GE 92.36 (+0.20%)

DIS 96.26 (-0.29%)

AMC 4.57 (+3.63%)

PFE 40.49 (-0.42%)

PYPL 75.70 (-1.33%)

NFLX 300.49 (-1.73%)

S&P 500 4,005.59 (+0.07%)

DOW 32,522.38 (-0.12%)

QQQ 311.03 (+0.22%)

AAPL 160.14 (+0.54%)

MSFT 276.13 (+0.86%)

META 202.54 (+0.19%)

GOOGL 105.11 (+0.18%)

AMZN 100.14 (-0.47%)

TSLA 197.17 (-0.21%)

NVDA 269.77 (+2.97%)

NIO 9.43 (+1.73%)

BABA 85.12 (+1.70%)

AMD 96.76 (+0.87%)

T 18.57 (+0.16%)

F 11.86 (+1.19%)

MU 58.69 (+0.10%)

CGC 1.97 (-0.25%)

GE 92.36 (+0.20%)

DIS 96.26 (-0.29%)

AMC 4.57 (+3.63%)

PFE 40.49 (-0.42%)

PYPL 75.70 (-1.33%)

NFLX 300.49 (-1.73%)

S&P 500 4,005.59 (+0.07%)

DOW 32,522.38 (-0.12%)

QQQ 311.03 (+0.22%)

AAPL 160.14 (+0.54%)

MSFT 276.13 (+0.86%)

META 202.54 (+0.19%)

GOOGL 105.11 (+0.18%)

AMZN 100.14 (-0.47%)

TSLA 197.17 (-0.21%)

NVDA 269.77 (+2.97%)

NIO 9.43 (+1.73%)

BABA 85.12 (+1.70%)

AMD 96.76 (+0.87%)

T 18.57 (+0.16%)

F 11.86 (+1.19%)

MU 58.69 (+0.10%)

CGC 1.97 (-0.25%)

GE 92.36 (+0.20%)

DIS 96.26 (-0.29%)

AMC 4.57 (+3.63%)

PFE 40.49 (-0.42%)

PYPL 75.70 (-1.33%)

NFLX 300.49 (-1.73%)

S&P 500 4,005.59 (+0.07%)

DOW 32,522.38 (-0.12%)

QQQ 311.03 (+0.22%)

AAPL 160.14 (+0.54%)

MSFT 276.13 (+0.86%)

META 202.54 (+0.19%)

GOOGL 105.11 (+0.18%)

AMZN 100.14 (-0.47%)

TSLA 197.17 (-0.21%)

NVDA 269.77 (+2.97%)

NIO 9.43 (+1.73%)

BABA 85.12 (+1.70%)

AMD 96.76 (+0.87%)

T 18.57 (+0.16%)

F 11.86 (+1.19%)

MU 58.69 (+0.10%)

CGC 1.97 (-0.25%)

GE 92.36 (+0.20%)

DIS 96.26 (-0.29%)

AMC 4.57 (+3.63%)

PFE 40.49 (-0.42%)

PYPL 75.70 (-1.33%)

NFLX 300.49 (-1.73%)

LON:NIPT

Premaitha Health - NIPT Share Forecast, Price & News

GBX 9.10

+0.20 (+2.25%)

(As of 11/6/2018)

Add

Today's Range: 9.10
▼
9.10
50-Day Range: 9.10
▼
9.10
52-Week Range: 3.78
▼
14.80

Volume: 1.57 million shs
Average Volume: 1.35 million shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Premaitha Health (LON:NIPT) Stock

Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

Read More

Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

NIPT Stock News Headlines

March 18, 2023 | finance.yahoo.com

Non-Invasive Prenatal Testing (NIPT) Market Growth (2022-2030) | Industry Share, Size, Trends and Global Forecast Report

March 9, 2023 | fool.co.uk

Premaitha Health

March 22, 2023 | PressReach (Ad)

Stocks Positioned For The Year

This breakthrough stock has bright future this decade.

February 23, 2023 | uk.finance.yahoo.com

Non-invasive Prenatal Testing Global Market Report 2023

February 19, 2023 | marketwatch.com

Non-Invasive Prenatal Testing (NIPT) Market 2023: A Status of Top Regions and Companies with Growth Prospects

July 12, 2022 | marketwatch.com

India Non-Invasive Prenatal Testing (NIPT) Market Size to reach 62 Million USD by 2022-2028

March 6, 2022 | fool.co.uk

Persimmon (LSE:PSN)

November 10, 2021 | lse.co.uk

Premaitha Health Share Chat

March 22, 2023 | PressReach (Ad)

Stocks Positioned For The Year

This breakthrough stock has bright future this decade.

January 11, 2021 | fool.co.uk

December 23, 2020 | lse.co.uk

Recent Broker Ratings for Panmure Gordon

November 28, 2020 | marketwatch.com

Non invasive prenatal testing nipt market : Industry Development Scenario and Forecast

May 2, 2020 | finance.yahoo.com

Healthcare Industry Trends And Its Impact On Premaitha Health PLC (LON:NIPT)

May 2, 2020 | finance.yahoo.com

What Investors Should Know About Premaitha Health PLC’s (LON:NIPT) Financial Strength

May 2, 2020 | finance.yahoo.com

Was Premaitha Health PLC’s (LON:NIPT) Earnings Growth Better Than The Industry’s?

May 2, 2020 | finance.yahoo.com

Why Premaitha Health PLC’s (LON:NIPT) Ownership Structure Is Important

May 2, 2020 | finance.yahoo.com

Is There Now An Opportunity In Premaitha Health PLC (LON:NIPT)?

May 2, 2020 | finance.yahoo.com

Premaitha Health PLC’s (LON:NIPT) Shift From Loss To Profit

May 2, 2020 | finance.yahoo.com

Who Owns Premaitha Health PLC (LON:NIPT)?

January 17, 2020 | www.benzinga.com

Non Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research®

January 17, 2020 | www.marketwatch.com

Non Invasive Prenatal Testing (NIPT) Market worth $13.1 Billion by 2027- Exclusive Report by Meticulous Research(R)

January 16, 2020 | www.marketwatch.com

Non-invasive Prenatal Testing (NIPT) Market Opportunities, Size, Share, Emerging Trends, Technological Innovation And Forecasts To 2025

November 18, 2019 | www.marketwatch.com

Non-invasive Prenatal Testing (NIPT) Market Precise Study on Factors, Market Drivers and Key Players Strategies Analyzed Till 2025

September 23, 2019 | www.marketwatch.com

Non-invasive Prenatal Testing (NIPT) Market Is Estimated To Expand At a Healthy CAGR in the Upcoming Forecast 2025

September 17, 2019 | www.marketwatch.com

Non-invasive Prenatal Testing (NIPT) Market:Overview and scope industry Size,Leading Players and Forecast to 2023

August 28, 2019 | www.marketwatch.com

Global Non-invasive Prenatal Testing (NIPT) Market will grow at a CAGR of 17.5% by 2019-2025

June 14, 2019 | www.marketwatch.com

Global Non-invasive Prenatal Testing Market Will Grow at a Cagr of 17.5% During the Forecast Period 2019-2025

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive NIPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Premaitha Health and its competitors with MarketBeat's FREE daily newsletter.

NIPT Company Calendar

Last Earnings: 12/29/2017
Today: 3/22/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Industry: Medical Laboratories & Research
Sub-Industry: N/A
Sector: Medical
Current Symbol: LON:NIPT
Previous Symbol: LON:VIY
CUSIP: N/A
CIK: N/A
Web: www.premaitha.com
Phone: +44-161-6676865
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

Key Executives

Dr. Stephen Little (Age 61)
Exec. Vice Chairman

Mr. Barry Hextall
CFO, Sec. & Exec. Director

Mr. Peter Collins (Age 59)
Chief Bus. Officer & Exec. Director

Mr. Lyn Fafydd Rees (Age 45)
CEO & Director

Dr. Chia-Han Chan (Age 42)
Chief Scientific Officer & Director

Key Competitors

View All Competitors

NIPT Stock - Frequently Asked Questions

How were Premaitha Health's earnings last quarter?: Premaitha Health PLC (LON:NIPT) released its quarterly earnings data on Friday, December, 29th. The company reported ($2.00) earnings per share for the quarter. The company had revenue of $2.71 million for the quarter.
What other stocks do shareholders of Premaitha Health own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include IQE (IQE), Avanti Communications Group (AVN), Chesapeake Utilities (CPK), Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Scancell (SCLP), Sirius Minerals (SXX), Advanced Micro Devices (AMD) and Aviva (AV).

What is Premaitha Health's stock symbol?: Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."
How do I buy shares of Premaitha Health?: Shares of NIPT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.
How can I contact Premaitha Health?: Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The official website for the company is www.premaitha.com. The company can be reached via phone at +44-161-6676865.

This page (LON:NIPT) was last updated on 3/22/2023 by MarketBeat.com Staff

Web Analytics

Get 30 Days of MarketBeat All Access Free

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial